Logo image of CYT

CYTEIR THERAPEUTICS INC (CYT) Stock Analyst Ratings

USA - NASDAQ:CYT - US23284P1030 - Common Stock

3.02 USD
-0.07 (-2.27%)
Last: 3/15/2024, 8:00:01 PM
3.1 USD
+0.08 (+2.65%)
After Hours: 3/15/2024, 8:00:01 PM
Buy % Consensus

45

ChartMill assigns a Buy % Consensus number of 45% to CYT. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 3.06. This target is 1.32% above the current price.
CYT was analyzed by 8 analysts. The buy percentage consensus is at 45. So analysts seem to be rather negative about CYT.
In the previous month the buy percentage consensus was at a similar level.
CYT was analyzed by 8 analysts. More opinions would make the average more meaningful.

Related screens

CYT Historical Analyst RatingsCYT Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -31 -28 -25 -22 -19 -16 -13 -10 -7 -4 -1 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 3.023.033.063.063.15 - 0.33% 1.32% 1.32% 4.30%

Related screens

CYT Current Analyst RatingCYT Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2024-01-05 B of A Securities Downgrade Neutral -> Underperform
2023-05-12 Wedbush Reiterate Outperform -> Outperform
2023-02-03 Morgan Stanley Downgrade Equal-Weight -> Underweight
2023-01-30 B of A Securities Downgrade Buy -> Neutral
2023-01-20 JP Morgan Downgrade Overweight -> Neutral
2022-09-09 Morgan Stanley Downgrade Overweight -> Equal-Weight
2022-02-07 Northland Capital Markets Initiate Outperform
2021-07-13 Wedbush Initiate Outperform
2021-07-13 JP Morgan Initiate Overweight
2021-07-13 B of A Securities Initiate Buy
2021-07-13 Morgan Stanley Initiate Overweight

CYTEIR THERAPEUTICS INC / CYT FAQ

Can you provide the average price target for CYTEIR THERAPEUTICS INC stock?

8 analysts have analysed CYT and the average price target is 3.06 USD. This implies a price increase of 1.32% is expected in the next year compared to the current price of 3.02.


Can you provide the consensus rating for CYTEIR THERAPEUTICS INC stock?

The consensus rating for CYTEIR THERAPEUTICS INC (CYT) is 45 / 100 . This indicates that analysts generally have a neutral outlook on the stock.


Can you provide the analyst count for CYTEIR THERAPEUTICS INC stock?

The number of analysts covering CYTEIR THERAPEUTICS INC (CYT) is 8.